Find clinical trials for M.D. Anderson. Search for M.D. Anderson clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 529
Active & Responsive
Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions
for
Premalignant Lesion
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06561087
Phase2, Recruiting
Active & Responsive
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
for
Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06066424
Phase1, Recruiting
Active & Responsive
What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care
for
Breast Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 30+
Code: NCT04794816
Recruiting
Active & Responsive
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
for
Chronic Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06817720
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07283679
Phase1, Phase2, Recruiting
New
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07407920
Phase2, Recruiting
New
Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
for
T-cell Acute Lymphoblastic Leukemia, Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 12 - 30
Code: NCT07513129
Phase1, Recruiting
New
Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer
for
Pancreatic Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07377526
Phase1, Phase2, Recruiting
New
Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML